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We have investigated the properties of murine leukemia virus Gag mutants in which the p12-CA cleavage site is altered. In one mutant, the
cleavage is blocked; in the other, the conserved proline at the N-terminus of CA has been replaced with glycine. No infectivity was detected in
either mutant. Mutant particles cannot synthesize full-length DNA upon infecting permissive cells. Particles composed of a mixture of wild-type
and mutant proteins have severely impaired infectivity. These mixed particles are defective in their ability to synthesize DNA upon infection, but
this defect is less severe than the loss of infectivity. Thus, proteins lacking the correct N-terminus of CA inhibit DNA synthesis and also interfere
with formation or integration of a full-length, normal provirus. The results imply that CA proteins function as part of a large, highly organized
structure in reverse transcription and apparently at a later step as well.
Published by Elsevier Inc.Keywords: Retroviruses; Capsid proteins; Infectivity; Reverse transcription; Dominant negative; Trans-dominant; Phenotypic mixing; Virus maturationIntroduction
The principal structural component of a retrovirus particle is
the virus-coded Gag protein. After the particle is released from
the virus-producing cell, Gag is cleaved by the viral protease
(PR) into a series of cleavage products, always including (from
N- to C-terminus) matrix (MA), capsid (CA), and nucleocapsid
(NC). This series of cleavage events is termed “maturation” of
the particle and is essential for infectivity (Swanstrom andWills,
1997).
The structure of the CA protein of HIV-1 has been
investigated in detail, using both nuclear magnetic resonance
and X-ray crystallography. Retroviral CA proteins are composed
of two domains connected by a flexible linker. Their N-terminal⁎ Corresponding author. Fax: +1 301 846 6013.
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doi:10.1016/j.virol.2005.12.012residue is always proline. Following the cleavage event that
generates this N-terminus, the first ∼50 amino acids of CA fold
into a β-hairpin, and the proline forms a buried salt bridge with
an internal aspartate residue (Gamble et al., 1996; Gitti et al.,
1996; Tang et al., 2002).
Maturation entails a drastic change in the morphology of the
virion. One of the hallmarks of this change is the appearance of
the “mature core” of the particle, a densely staining body in the
interior of the virion. Recent studies on structures formed in
vitro by purified CA proteins of HIV-1 and murine leukemia
virus (MLV) show that the mature core is composed of CA
molecules. Within this core, CA proteins are evidently arranged
in a lattice in which the N-terminal domains of groups of six CA
molecules are in hexameric rings; each ring is joined to
neighboring rings by dimeric contacts between C-terminal
domains (Ganser et al., 2003; Li et al., 2000; Mortuza et al.,
2004). The planar hexagonal lattice is closed by the presence of
twelve pentameric “defects” (Ganser et al., 1999).
Several types of evidence suggest that the correct mature
core structure is essential for infectivity, and that this structure
depends in turn upon the presence of the proline at the N-
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by another amino acid (Fitzon et al., 2000) (see below) or in
which the release of CA from Gag is inhibited by a change in the
cleavage site (Gottlinger et al., 1989; Oshima et al., 2004) are
not infectious. Similar results are also observed when the
aspartate partner in the salt bridge in HIV-1 CA is replaced by
alanine (Tang et al., 2003).
In the present work, we have analyzed the properties of
MLV mutants at the N-terminus of CA. We have also
studied MLV particles containing a mixture of mutant and
wild-type proteins. The mutants investigated here included
one in which maturation cleavage at the N-terminus of CA
is blocked by a change in the residue preceding proline in
Gag and one in which the N-terminal proline in CA was
replaced by glycine. We found that both of these mutants
potently inhibit the functions of the wild-type, reducing the
specific infectivity of the mixed particles. The data indicate
that these mutant proteins interfere with the ability of the
particle to synthesize viral DNA upon entering the new host
cell. The results support the hypothesis that an organized
assemblage of CA molecules in the mature particle plays a
crucial role in facilitating reverse transcription; this func-
tional complex is evidently disrupted by the presence of
mutant proteins in the particle, even when wild-type proteins
are in excess. However, the inhibition of DNA synthesis did
not appear to be sufficient to explain the loss of infectivity
in the mixed particles. Thus, the data further suggest that
the correct structure of the mature core is also required for
the correct formation of the final DNA product or for a
subsequent step, such as integration of the DNA into the
chromosome of the host cell.
Results
Properties of “S2G”
The MLV Gag protein, Pr65, is cleaved into MA, p12, CA,
and NC during virus maturation, as indicated in Fig. 1A. WeFig. 1. Cleavage of MLV Gag and CA-containing protein species in S2G virions. (A)
NC; (middle row) production of p42 in mutants such as S2D which block cleavage at
site 3 is blocked. (B) Particles of S2G (lane 1), S2D (lane 2), wild-type MLV (lane
immunoblotting with anti-CA antiserum. Mobilities of Pr65Gag, p30CA, and the p42have previously described mutants at cleavage site 2 (“S2”), the
p12-CA cleavage site (Oshima et al., 2004). We found that
replacement of the tyrosine at the C-terminus of p12 (the P1
position of S2) with a charged residue, such as aspartate,
completely blocked cleavage at this site. This mutant was
designated S2D. The location of this mutant in the Gag protein
is illustrated schematically in Fig. 1A. We also observed that
cleavage at the other two sites of maturation cleavage,
particularly the CA-NC cleavage site, was somewhat inefficient
in S2D particles (Oshima et al., 2004). In the present work, we
have also investigated a mutant in which the proline at the N-
terminus of CA (i.e., the P1′ position of site 2) was replaced by
glycine; we refer to this mutant as “S2G” for convenience.
Fig. 1B shows an analysis of S2G particles, using immuno-
blotting with anti-CA antiserum. Also included in the figure, for
comparison, are particles of S2D (in which there is no free CA,
but only the 42-kDa p12-CA fusion protein (Oshima et al.,
2004)), as well as wild-type and PR− particles. It can be seen that
the S2G profile contains a substantial amount of CA protein.
There is also a significant level of a protein migrating just
slightly faster than the 42-kDa protein of S2D; this is p40, the
CA-NC fusion protein, since it reacts with anti-NC as well as
anti-CA antisera (data not shown). p40 was previously observed
in S3R particles, in which cleavage between CA and NC was
blocked (Oshima et al., 2004) (see Fig. 1A). Thus, despite the
fact that this mutant is altered at the N-terminus of CA, it
exhibits efficient cleavage at the N-terminus, but only partial
cleavage at the C-terminus, of CA. Both S2G and S2D particles
also contain two larger intermediates, presumably MA-p12-CA
and p12-CA-NC.
The morphology of S2G particles was also examined.
Released virions were collected for thin-section electron
microscopy by immunoprecipitation with anti-SU antibody as
described (Oshima et al., 2004). We found (Fig. 2) that they are
similar to wild-type MLV particles, but that their structure is
considerably more irregular. For example, many particles
contain condensed material in their interiors but lack a clearly
defined core. Other particles resemble immature particles, but(top row) Scheme showing normal cleavage of MLV Gag into MA, p12, CA, and
site 2 (between p12 and CA); (bottom row) production of p40 when cleavage at
3), and PR− MLV (lane 4) were collected from culture fluid and analyzed by
and p40 cleavage intermediates are indicated.
Fig. 2. Morphology of S2G virions. Virions were collected on protein G-
Sepharose beads as described (Campbell et al., 2002). (A) Wild-type MLV. (B)
S2G. Scale bars: 100 nm.
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particle is incomplete. Examples of these morphologies are in
the field shown in Fig. 2B.
We also measured infectivity of S2G particles, using either a
luciferase reporter or the green fluorescent protein (GFP)-based
system described earlier (Oshima et al., 2004). No infectivity
was detected in either of these assays, since the luciferase or GFP
activity induced by the mutant particles was no higher than in
cultures “mock-infected” using culture fluids from cells
transfected with the empty vector pGCcos3neo; the luciferase
data are shown in Table 1. The specific infectivity of these
particles is at least several hundred-fold below that of wild-type
particles.
We have previously analyzed the genomic RNA in S2D
mutant particles (Oshima et al., 2004). These tests gave no
suggestion that packaging of the RNAwas reduced in the S2D
particles. However, it was conceivable that packaging is
defective in S2G particles. We therefore produced S2G particles,
along with wild-type control particles, in 293T cells stably
transfected with the MLV-derived vector pLXSH (Miller et al.,
1993) (see below). We analyzed the particles for hygromycin
phosphotransferase (hph) RNA by real-time RT-PCR. No
significant differences between hph RNA contents of S2G and
wild-type (or S2D) virions were observed (data not shown).
Properties of virions containing a mixture of wild-type and
S2D or S2G Gag proteins
The focus of the present study was the biological properties
of MLV particles composed of a mixture of wild-type andTable 1
Biological activity of MLV particles containing S2D or S2G Gag
Sample LUC Protein, μg/ml
WT 30,876 ± 1344 370
S2D 37 ± 6 395
S2G 43 ± 12 483
RT− N.D. 363
pGCcos3neo 30 ± 0 341
Virus particles were produced by transfecting pLXSH-containing cells with 4 μg of
DNA. Infectivity was assessed by measuring luciferase activity in extracts of 293T/M
cells was used to measure reverse transcription. The single-copy cellular gene CCR5 w
relative light units per 20 μl of cell extract. N.D., not determined.mutant Gag proteins. We measured infectivity by co-transfect-
ing 293T cells with an MLV-based reporter vector along with
the MLV proviral clones being analyzed.
A series of 293T cultures was transfected with constant
amounts of reporter vectors and wild-type MLV plasmid
together with graded amounts of S2D or S2G mutant plasmid.
Virions in the culture fluid of the transfected cells were
collected and assayed for their Gag protein profile and their
infectivity. Immunoblots are shown in Fig. 3. The only
proteins detected with anti-p30CA antiserum in the wild-type
particles (lanes 1–4) are p30CA and a small amount of the
uncleaved precursor, Pr65Gag. As noted above, however, the
S2D clone (lane 10) gives rise to virions that contain p42 (the
p12-CA fusion protein) and two larger intermediates in
addition to Pr65Gag (Oshima et al., 2004). When increasing
amounts of S2D plasmid are added to the wild-type plasmid
(lanes 5–9), these same species, as well as free CA, are
observed. A culture transfected with equal amounts of the two
plasmids (lane 7) produces particles containing approximately
equal amounts of CA and p42. Thus, neither of the MLV
plasmids affects the contribution of the other plasmid to the
virions produced by the co-transfected cells (It is interesting to
note one deviation from this simple statement. There is more
free CA in lane 9 than in lanes 5–8, despite the fact that CA is
only produced from the wild-type plasmid, which is at a
constant level in lanes 5–9. It seems likely that virus assembly
is cooperative, so that the expression of S2D Gag increases
virion production and, consequently, the export of wild-type
Gag in virus particles.) Similar results were obtained in the
cultures co-transfected with wild-type plasmid and increasing
amounts of S2G (lanes 12–17).
Infectivity of mixed virus stocks like those shown in lanes 5–
9 and 12–16 was assessed by infecting 293T cells expressing
MCAT (Albritton et al., 1989) with them and assaying the
infected cultures 48 h later for luciferase activity. Normalized
results of these assays are shown in Fig. 4. It is evident that the
infectivity values are substantially lower in the mixed particles
than in the wild-type controls; for example, particles with equal
amounts of wild-type and S2D protein have a titer several
hundred-fold below that of the wild-type control. Similar results
have also been obtained in assays on NIH3T3 cells (data not
shown). (In the experiment presented here, S2D was more
detrimental in its effects on infectivity than S2G. However, in
some experiments, S2G has been fully as deleterious as S2D.Hph copies CCR5 copies Hph/CCR5
16,472 ± 4664 36,641 ± 2289 0.449
0.9 ± 1.8 73,530 ± 7035 0.00001
4.6 ± 5.3 89,833 ± 13,016 0.00005
14.8 ± 9.8 80,719 ± 16,743 0.0002
8.5 ± 5.7 100,117 ± 13,844 0.00008
wild-type or mutant MLV plasmid. Each plate also received 4 μg of pBabe-Luc
CAT cells infected by the particles, while the amount of hph DNA in the infected
as used as a DNA recovery control. Luciferase activity (“LUC”) is expressed as
Fig. 3. Composition of virions produced following co-transfection of mutant and wild-type MLV plasmids. 10-cm dishes of 293Tcells were transfected with 1 (lane 1),
2 (lane 2), 4 (lane 3), or 8 (lane 4) μg of wild-type plasmid, or with 4 μg of wild-type plasmid + 1 (lane 5), 2 (lane 6), 4 (lane 7), 8 (lane 8), or 12 (lane 9) μg of S2D
plasmid, or with 12 μg S2D (lane 10) or pGCcos3neo (lane 11) plasmid, or with 4 μg wild-type plasmid + 1 (lane 12), 2 (lane 13), 4 (lane 14), 8 (lane 15), or 12 (lane
16) μg S2G plasmid, or 12 μg S2G plasmid (lane 17). All plates also received 4 μg each of pBabe-Luc and pLZRS-EGFP DNAs. The plasmid vector pGCcos3neo was
included in the transfections as needed to maintain the total amount of DNA added to each plate at 24 μg. Virions produced by the transfected cultures were analyzed
by immunoblotting with anti-CA antiserum.
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between experiments).
It seemed possible that these results are due to some
peculiarity of the luciferase reporter system used here. To test
this possibility, we included pLZRS-EGFP, as well as pBABE-
Luc, in the co-transfections with mixtures of mutant and wild-
type plasmids and assayed the culture fluids for the titer of GFP-
inducing infectious units as well as for the infectivity of the
luciferase vector. The relative titers obtained with the two
reporter systems were virtually superimposable (data not
shown). Thus, the reduced infectivity of mixed particles
containing S2D or S2G protein is evidently independent of
the assay used and presumably reflects an intrinsic property of
these virions.
As noted above, S2G particles are inefficiently cleaved at
the C-terminus of CA, so that they give rise to a significant
amount of the p40 CA-NC fusion protein (Figs. 1B, 3). It
seemed possible that this property was responsible for the
ability of S2G Gag to reduce the infectivity of mixed particlesFig. 4. Effects of S2D and S2G plasmids on infectivity of mixed particles.
Virions were produced as in Fig. 3. Luciferase activities (corrected for small
differences in protein concentration in extracts of infected cells) were divided
by the activity obtained using 4 μg of wild-type plasmid +12 μg of
pGCcos3neo DNA. Closed circles, S2D; open circles, S2G.(Fig. 4). To test this hypothesis, we also assessed the
infectivity of particles produced following co-transfection of
wild-type and S3R MLV; the leucine at the C-terminus of CA
has been replaced in S3R with arginine, completely prevent-
ing cleavage between CA and NC (Oshima et al., 2004). The
results of these tests are shown in Fig. 5. As can be seen in
Fig. 5B, the admixture of S3R Gag protein (shown in Fig.
5A) had almost no effect on the infectivity of the particles.
Thus, the inhibition of wild-type infectivity by the S2G Gag
protein is probably not due to the inefficiency of cleavage at
site 3.
DNA synthesis upon infection with particles containing both
wild-type and mutant Gag proteins
It was of interest to determine whether the presence of the
S2D or S2G proteins in the mixed particles interfered with the
ability of the particles to synthesize viral DNA upon entry into
susceptible cells. We therefore measured reverse transcription
products, using real-time PCR, at 24 h after infection with these
particles. One potential technical problem in these experiments
is the presence in the virus preparations of plasmid DNA from
the transient transfection used to produce the particles. To
eliminate this background, we adopted the following strategy.
293T cells were first stably transfected with the MLV-derived
vector pLXSH, which contains the coding sequence for hph
(Miller et al., 1993). The wild-type and mutant MLV clones
(together with pBABE-Luc, which enabled us to conveniently
measure the infectivity of the progeny viruses) were then co-
transfected into these hygromycin-resistant cells, and virus
produced following this transient transfection was finally
analyzed for its ability to synthesize hph DNA following
infection of permissive cells as described in Materials and
methods. Cells were lysed 24 h after infection and assayed for
hph DNA by real-time PCR. It should be noted that hph DNA
synthesis depends upon completion of the preceding steps in
reverse transcription, i.e., (−) strand strong-stop DNA synthesis
and the first strand transfer event. To control for possible
variation in recovery of DNA from the infected cells, we also
Fig. 5. Properties of virions produced following co-transfection of wild-type and S3R plasmid DNA. 10-cm dishes of 293T cells were transfected with 4 μg of wild-
type plasmid + 4 or 8 μg of S3R or S2G plasmid. Control cultures were transfected with 4 μg of wild-type or mutant plasmids alone. All cultures also received 4 μg of
pBabe-Luc DNA. Total plasmid DNA in the transfections was kept constant by addition of pGCcos3neo DNA. (A) Protein composition of the virions from the
transfected cells, as analyzed by immunoblotting with anti-CA antiserum; (B) infectivity of the virions, assayed by infecting NIH3T3 cells and measuring luciferase
activity 48 h later. Luciferase values were divided by the activity obtained with 4 μg wild-type plasmid + 8 μg pGCcos3neo DNA. Closed circles: effect of S3R; open
circles: effect of S2G.
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extracts. The variation among all samples with respect to CCR5
content was less than 3-fold (data not shown).
We found (Table 1) that particles containing only S2D or
S2G mutant proteins were incapable of synthesizing hph DNA;
that is, the corrected values of “hph DNA” in the infected cells
were always at least 5000-fold lower than in the wild-type
controls and were never significantly higher than those in mock-
infected control cells. Thus, cleavage at the N-terminus of CA is
apparently essential for reverse transcription of the full-length
viral genome, and replacement of the conserved proline residue
with glycine at this site is also incompatible with synthesis of
the entire DNA product. We then measured hph DNA
synthesized in cells infected with the virions containing
mixtures of wild-type and S2D or S2G proteins. ResultsFig. 6. Effect of S2D (A) and S2G (B) on infectivity of and DNA synthesis by MLV p
Fig. 3 and were lysed 24 h later for assay of hph DNA (closed circles) and for 2-LT
activity (dashed lines; data as in Fig. 4). Replicate cultures were also passaged fo
measurements were also corrected for differences in recovery of CCR5 DNA.(following normalization to the wild-type control) are shown in
the closed circles in Fig. 6. It is obvious that as the proportion of
mutant protein in the virion increases, the particle becomes
progressively impaired in its ability to perform reverse
transcription. It is striking to note, however, that the inhibition
of viral infectivity induced by the presence of the mutant
proteins (dashed lines) is, in general, significantly greater than
the inhibition of hph DNA synthesis (closed circles). In other
words, many particles which synthesize DNA in newly infected
cells still fail to establish infection.
In an effort to further define the block in infection imposed
by the presence of Gag proteins with alterations at the N-
terminus of CA, we also measured the level of hph DNA in
cells that had been passaged for 11 days following infection.
As shown in the open circles in Fig. 6, the relative levels ofarticles. 293T cells expressing MCATwere infected with the virions analyzed in
R circular DNA (triangles). Replicate plates were lysed 48 h later for luciferase
r 11 days and then lysed and assayed for hph DNA (open circles). All DNA
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with the relative levels of infected cells (dashed lines). These
results suggest that a uniform fraction – perhaps all or nearly
all – of the hph DNA molecules that were stably associated
with the infected cells were present in functional, integrated
proviruses.
It seemed possible that the hph DNA molecules that are not
stably associated with the cells could be blocked with respect to
entry into the nucleus, prior to proviral integration. The
presence of closed 2-LTR circular DNA is frequently taken as
an indicator of entry of viral DNA into the nucleus (e.g., Yuan et
al., 2002). We therefore measured the level of 2-LTR circles in
the cells 24 h after infection. As shown in Fig. 6 (triangles), the
relative levels of these circles are significantly higher than the
levels of infection or of stable hph DNA and correspond closely
with the level of hph DNA in the 24-h lysates. Thus, there is no
indication that the nuclear entry of DNAmolecules is blocked in
the cells infected with the mixed virions.
Discussion
We have shown here (Fig. 4) that two MLV Gag proteins
which lack the absolutely conserved proline residue at the N-
terminus of the capsid domain are potent dominant-negative
inhibitors of infectivity when present in virions together with
the wild-type protein. In one of these, S2D, the change in the
Gag coding sequence prevents cleavage at the p12-CA
boundary, so that no free N-terminus of CA is formed during
virus maturation. In contrast, the other mutant studied, S2G,
undergoes efficient cleavage at this site, but the resulting N-
terminal residue is glycine rather than proline. (Cleavage at the
C-terminus of CA is, however, incomplete in S2G mutant
particles (Fig. 1B). It is somewhat surprising that the cleavage at
site 3 is inhibited by the replacement of proline with glycine at
site 2).
We attempted to identify the point in the viral replication
cycle that is blocked in the particles containing both wild-type
and mutant Gag proteins. We found (Fig. 6) that the proportion
of mixed particles synthesizing late (i.e., hph) DNA products is
reduced in the mixed particles but is still significantly higher
than the proportion that successfully establishes infection. The
presence of the mutant Gag proteins also has a less drastic
effect on the synthesis of 2-LTR circular DNA than on
infection or stable association of viral DNA with the cells,
presumably in integrated proviruses. Taken together, these
results imply that there is a fraction of the phenotypically
mixed virions which synthesizes DNA, and that this DNA
enters the nucleus but is not integrated into cellular DNA. One
hypothesis that could explain these results is that these DNA
molecules are unsuitable substrates for integrase: perhaps there
are subtle defects in their ends, as has been previously
described for mutants in NC (Gorelick et al., 1999) and, in
HIV-1, in the RNase H domain of reverse transcriptase (Julias
et al., 2002).
The ability of the mutant proteins to interfere with the
function of the wild-type CA in the mixed particles implies that
wild-type proteins do not function as monomers, but as part of alarge, organized assemblage; this large functional unit is
apparently disrupted and inactivated by the presence of mutant
proteins within it. This structure is presumably the mature core
of the virion. Mutants elsewhere within HIV-1 CA have
previously been shown to interfere with infectivity in mixed
particles (Furuta et al., 1997; Mammano et al., 1994; Trono et
al., 1989). Interestingly, a recent study of poliovirus pointed out
that genes in which mutations show trans-dominant effects can
be particularly attractive targets for antiviral therapy; indeed,
screening for trans-dominance can be used in the selection of
drug targets (Crowder and Kirkegaard, 2005). Taken together,
these observations highlight the potential utility of particle
assembly and maturation as potential antiretroviral drug targets.
Unfortunately, the lack of basic molecular understanding and of
convenient screens has made it impossible to exploit these
targets to date.
The results presented here have, in part, been foreshadowed
by previous reports using low doses of PR inhibitors on HIV-1.
It was found in these studies that drug concentrations which
only prevent cleavage in a small fraction of the Gag and Pol
proteins lead to production of noninfectious particles (Kaplan et
al., 1993; Krausslich, 1992). It was also reported that the loss of
infectivity in these particles is more severe than the defect in
reverse transcription (Kaplan et al., 1993). Thus, these results,
like those in the present study, imply that a minority of
uncleaved viral proteins (as in the S2D:wild-type mixed
particles) can block infectivity without blocking DNA synthe-
sis. However, they do not provide information as to which
cleavage sites are so critical for infection.
The present results also add to the growing body of evidence
indicating that the mature core of a retrovirus particle plays a
crucial role in reverse transcription. Thus, mutations in HIV-1
CA that alter the stability of the core in viral lysates affect the
kinetics of DNA synthesis during infection (Forshey et al.,
2002). In addition, mutations that replace either the N-terminal
proline or its aspartate partner in the buried salt bridge in CA
interfere with both formation of the normal core morphology
and the initiation of viral DNA synthesis upon infection (Fitzon
et al., 2000; Tang et al., 2003; von Schwedler et al., 1998).
These studies all suggest that uncoating of the viral genome is a
critical, tightly regulated step in infection which requires the
correct conformation of the N-terminus of CA. In MLV also,
mutants near the N-terminus of CA have been shown to be
impaired in reverse transcription (Auerbach et al., 2003).
However, we are not aware of prior reports implicating CA in
the successful completion of integration-competent viral DNA
copies, as suggested by the data in Fig. 6. In this connection, it is
interesting to note that retroviral CA proteins are also the target
of several cellular restriction systems, including Fv-1, Lv-1, and
Ref-1 (Lee and KewalRamani, 2004). It appears that some of
these systems interfere with infection before viral DNA
synthesis (Stremlau et al., 2004; Towers et al., 2000), while
others interfere with a subsequent event (Jolicoeur and Rassart,
1980; Yang et al., 1980); again, these observations would
suggest that CA functions both in the initiation of reverse
transcription and in its successful completion or in the
integration of the DNA product.
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Cells and viruses
All experiments described here were performed with full-
length Moloney MLV proviral clones ultimately derived from
the infectious clone pRR88 (Fu and Rein, 1993). Virus particles
were produced by transient transfection of 293T cells, using
Transit 293 (Mirrus) in accord with the manufacturer's
instructions. When viruses were to be analyzed for infectivity,
either pBABE-Luc, which contains the firefly luciferase gene
from pGL3 (Promega) in pBabe Puro (Morgenstern and Land,
1990), or pLZRS-EGFP, an MLV-based vector encoding GFP
(Dardalhon et al., 1999), was co-transfected with the MLV
proviral constructs being analyzed. Infectivity was then
measured by infecting either NIH3T3 cells or 293T cells
expressing the ecotropic MLV receptor MCAT (Albritton et al.,
1989) (a kind gift of J. Cunningham), and either enumerating
GFP-positive cells as described (Oshima et al., 2004) or
assaying cell extracts for luciferase activity using the Luciferase
Assay System (Promega) 48 h after infection. The cell extracts
were also assayed for total protein content using the BCA assay
system (Pierce) according to the manufacturer's instructions.
MLV containing a mutation at the active site of reverse
transcriptase, changing residues 223 and 224 from aspartate to
lysine and leucine, respectively (a kind gift from Robert
Gorelick, SAIC Frederick), was used as a negative control.
Except where specified otherwise, all techniques were as
described (Oshima et al., 2004).
Electron microscopy
Released virus was examined after it was collected by
immunoprecipitation on protein G-Sepharose beads as previ-
ously described (Campbell et al., 2002).
Viral RNA
Virions were assayed for hph RNAby real-time RT-PCR as
described (Hibbert et al., 2004).
Viral DNA synthesis
The ability of virus particles to perform DNA synthesis upon
infecting new host cells was assayed as follows. Viruses were
produced by transient transfection of 293T cells that had
previously been stably transfected with pLXSH (Miller et al.,
1993) and selected for hygromycin resistance. The virus
particles obtained following the transient transfection were
then used to infect 293T cells expressing MCAT. 24 h later, the
cells were lysed by the QIAamp DNA Mini Kit (Qiagen,
Valencia, CA), and the cell extracts were assayed for
hygromycin phosphotransferase (hph) DNA by real-time PCR
as described (Hibbert et al., 2004). Two-LTR circles were
assayed by real-time PCR using 5′-GTC TCG CTG TTC CTT
GGG AGG GTC-3′ as the forward primer, 5′-CAT CTG TTC
CTG ACC TTG ATC TGA-3′ as the reverse primer, and 5′FAM-GGC GTTACT TAA GCTAGC TTG CCA–TAMRA-3′
as the probe. These reagents were designed to anneal to
sequences found in both MLV and pLXSH. The extracts were
also assayed for the single-copy gene CCR5 by real-time PCR
in order to control for differences in recovery of DNA from the
extracts; these assays used 5′-CCA GAA GAG CTG AGA CAT
CCG-3′ for forward primer, 5′-GCC AAG CAG CTG AGA
GGT TAC T-3′ for reverse primer, and 5′FAM-TCCCCTA-
CAAGAAACTCTCCCCGG-TAMRA-3′ for probe. Plasmids
used as standards in these two assays were a kind gift of Robert
Gorelick.
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